SALMYCIN

This brand name is authorized in Nigeria.

Active ingredients

The drug SALMYCIN contains one active pharmaceutical ingredient (API):

1	Tetracycline UNII P6R62377KV - TETRACYCLINE HYDROCHLORIDE
	Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth.
	Read more about Tetracycline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2991	Capsule	SALMYCIN 250 CAPSULES CAP 250 mg 10 X 10 capsules	44 CMS-PP-390692 SALMYCIN 250 CAPSULES TETRACYCLINE CAPSULES BP 250MG Each capsule contains Tetracycline Hydrochloride BP 250mg Maize Starch BP 74.5mg Purified Talc BP 25.0 mg Colloidal Anhydrous Silicon BP 0.5 mg Size ‘1’ Red cap/Yellow body Empty hard gelatin capsules BP ( printed SAGAR with logo on cap both cap &SALMYCIN on body) 1.0 No. Apr-91 Drugs Nigerian Products 1010caps POM 1 11/21/2023 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA07	Tetracycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2991